Compare ADMA Biologics Inc (ADMA) vs Core Scientific Inc (CORZ) Price & Performance

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

CORZ trades at $22.80, up 6.39% today, while showing bearish technical signals with a net cash outflow of $525.6M in 2025. The company is pivoting from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. Despite missing earnings estimates for three consecutive quarters, analyst consensus remains strongly bullish with 86% buy ratings and a $33.43 price target.

The stock presents a high-risk, high-reward opportunity as the AI infrastructure transition accelerates. Near-term execution risks and negative profitability metrics contrast with substantial growth potential in the AI data center market. Wall Street optimism appears to outweigh current financial challenges, but investors should monitor cash flow improvements and contract execution.